pharmaceutical investing Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation to Expand the Clinical Research on IMO-2125
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT
Cascadia Expands Sulphide Mineralization with 106.62 m of 1.09% CuEq at the Carmacks Copper-Gold Project, Yukon
